INSIDER · CIK 1873905
Tak Paul Peter
Chief Executive Officer, Director at Candel Therapeutics, Inc. (CADL)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$3.2MSold on the market
1Companies
Sep 11, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 202618:12 | Sep 11, 2026from Sep 10, 2026 | CADLCandel Therapeutics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $11.28 | −280,245 | 113,321 | -71% | −$3.2M | ||
| Sep 11, 202618:12 | Sep 10, 2026 | CADLCandel Therapeutics, Inc. | Chief Executive Officer, Director | M · Exercise10b5-1 | $1.55 | +125,000 | 393,566 | +47% | $194K |